G100

G100 · Immune Design / Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for G100, covering 2020-09-09 to 2020-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142) [Phase 1, Phase 2]

See pricing